Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Lancet (London, England)
|
July 9, 2017
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G Gibson, Ian A Yang, John W Upham, et al.
The Journal of Allergy and Clinical Immunology
|
May 9, 2017
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology
Steven L Taylor, Lex E X Leong, Jocelyn M Choo, et al.
Respirology (Carlton, Vic.)
|
October 12, 2020
Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study
Tom J C Ruffles, Julie M Marchant, Ian B Masters, et al.
The European Respiratory Journal
|
September 30, 2021
<i>R</i> <i>othia mucilaginosa</i> is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease
Charlotte Rigauts, Juliana Aizawa, Steven L Taylor, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 16, 2019
Long-Term Azithromycin Reduces <i>Haemophilus influenzae</i> and Increases Antibiotic Resistance in Severe Asthma
Steven L Taylor, Lex E X Leong, Fredrick M Mobegi, et al.
The Lancet. Respiratory Medicine
|
February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
Holly R Keir, Amelia Shoemark, Alison J Dicker, et al.
ERJ Open Research
|
March 30, 2018
Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitis
Alice C-H Chen, Hai B Tran, Yang Xi, et al.
The Lancet. Respiratory Medicine
|
April 12, 2021
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 3, 2017
Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant Asthma
Richard Y Kim, James W Pinkerton, Ama T Essilfie, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Lancet (London, England)
|
July 9, 2017
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G Gibson, Ian A Yang, John W Upham, et al.
The Journal of Allergy and Clinical Immunology
|
May 9, 2017
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology
Steven L Taylor, Lex E X Leong, Jocelyn M Choo, et al.
Respirology (Carlton, Vic.)
|
October 12, 2020
Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study
Tom J C Ruffles, Julie M Marchant, Ian B Masters, et al.
The European Respiratory Journal
|
September 30, 2021
<i>R</i> <i>othia mucilaginosa</i> is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease
Charlotte Rigauts, Juliana Aizawa, Steven L Taylor, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 16, 2019
Long-Term Azithromycin Reduces <i>Haemophilus influenzae</i> and Increases Antibiotic Resistance in Severe Asthma
Steven L Taylor, Lex E X Leong, Fredrick M Mobegi, et al.
The Lancet. Respiratory Medicine
|
February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
Holly R Keir, Amelia Shoemark, Alison J Dicker, et al.
ERJ Open Research
|
March 30, 2018
Multiple inflammasomes may regulate the interleukin-1-driven inflammation in protracted bacterial bronchitis
Alice C-H Chen, Hai B Tran, Yang Xi, et al.
The Lancet. Respiratory Medicine
|
April 12, 2021
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 3, 2017
Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant Asthma
Richard Y Kim, James W Pinkerton, Ama T Essilfie, et al.
Page
of 11